Authors and Disclosures
Giovanni Battista Migliori1, Pei Min Thong1, Onno Akkerman, Jan-Willem Alffenaar, Fernando Álvarez-Navascués, Mourtala Mohamed Assao-Neino, Pascale Valérie Bernard, Joshua Sorba Biala, François-Xavier Blanc, Elena M. Bogorodskaya, Sergey Borisov, Danilo Buonsenso, Marianne Calnan, Paola Francesca Castellotti, Rosella Centis, Jeremiah Muhwa Chakaya, Jin-Gun Cho, Luigi Ruffo Codecasa, Lia D'Ambrosio, Justin Denholm, Martin Enwerem, Maurizio Ferrarese, Tatiana Galvão, Marta García-Clemente, José-María García-García, Gina Gualano, José Antonio Gullón-Blanco, Sandra Inwentarz, Giuseppe Ippolito, Heinke Kunst, Andrei Maryandyshev, Mario Melazzini, Fernanda Carvalho de Queiroz Mello, Marcela Muñoz-Torrico, Patrick Bung Njungfiyini, Domingo Juan Palmero, Fabrizio Palmieri, Pavilio Piccioni, Alberto Piubello, Adrian Rendon, Josefina Sabriá, Matteo Saporiti, Paola Scognamiglio, Samridhi Sharma, Denise Rossato Silva, Mahamadou Bassirou Souleymane, Antonio Spanevello, Eva Tabernero, Marina Tadolini, Michel Eke Tchangou, Alice Boi Yatta Thornton, Simon Tiberi, Zarir F. Udwadia, Giovanni Sotgiu, Catherine Wei Min Ong2 and Delia Goletti2
Istituti Clinici Scientifici Maugeri IRCCS, Tradate, Italy (G.B. Migliori, R. Centis, A. Spanevello); Yong Loo Lin School of Medicine, National University of Singapore, Singapore (P.M. Thong, C.W.M. Ong); University of Groningen, Groningen, the Netherlands (O. Akkerman); The University of Sydney, Sydney, New South Wales, Australia (J.-W. Alffenaar, J.-G. Cho); Westmead Hospital, Sydney (J.-W. Alffenaar, J.-G. Cho); Hospital Universitario San Agustín, Avilés, Spain (F. Álvarez-Navascués, J.A. Gullón-Blanco); National Tuberculosis Programme, Niamey, Niger (M.M. Assao-Neino); Centre Hospitalier Universitaire, Nantes, France (P.V. Bernard, F.-X. Blanc); Community Health Centre, Tombo, Sierra Leone (J.S. Biala); Moscow Research and Clinical Center for TB Control, Moscow, Russia (E.M. Bogorodskaya, S. Borisov); Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy (D. Buonsenso); University Research Co. LLC, Manila, the Philippines (M. Calnan); Niguarda Hospital, Milan, Italy (P.F. Castellotti, L.R. Codecasa, M. Ferrarese, M. Saporiti); Kenyatta University, Nairobi, Kenya (J.M. Chakaya); Liverpool School of Tropical Medicine, Liverpool, UK (J.M. Chakaya); Parramatta Chest Clinic, Parramatta, New South Wales, Australia (J.-G. Cho); Public Health Consulting Group, Lugano, Switzerland (L. D'Ambrosio); Melbourne Health Victorian Tuberculosis Program, Melbourne, Victoria, Australia (J. Denholm); University of Melbourne, Melbourne (J. Denholm); Amity Health Consortium, Johannesburg, South Africa (M. Enwerem); Universidade Federal da Bahia, Salvador, Brazil (T. Galvão); Hospital Universitario Central de Asturias, Oviedo, Spain (M. García-Clemente); Tuberculosis Research Programme SEPAR, Barcelona, Spain (J.-M. García-García); National Institute for Infectious Diseases 'L. Spallanzani' IRCCS, Rome (G. Gualano, G. Ippolito, F. Palmieri, P. Scognamiglio, D. Goletti); Instituto Vaccarezza, Buenos Aires, Argentina (S. Inwentarz, D.J. Palmero); Royal London Hospital of Barts Health National Health Service Trust, London, UK (H. Kunst, S. Tiberi); Queen Mary University, London (H. Kunst, S. Tiberi); Northern State Medical University, Arkhangelsk, Russian Federation (A. Maryandyshev); Istituti Clinici Scientifici Maugeri IRCCS, Pavia, Italy (M. Melazzini); Instituto de Doenças do Tórax, Universidade Federal do Rio de Janeiro, Rio de Janeiro, Brazil (F.C.Q. Mello); Instituto Nacional De Enfermedades Respiratorias Ismael Cosio Villegas, Mexico City, Mexico (M. Muñoz-Torrico); Community Health Center, Hastings, Sierra Leone (P.B. Njungfiyini; M.E. Tchangou); Amedeo di Savoia Hospital, Turin, Italy (P. Piccioni); Damien Foundation, Niamey, Niger (A. Piubello, M.B. Souleymane); University Hospital of Monterrey (Universidad Autonoma de Nuevo Leon), Monterrey, Mexico (A. Rendon); Hospital Transversal Moises Broggi-HGH, Barcelona (J. Sabriá); P.D. Hinduja National Hospital and Medical Research Centre, Mumbai, India (S. Sharma, Z.F. Udwadia); Universidade Federal do Rio Grande do Sul (UFRGS), Porto Alegre, Brazil (D.R. Silva); University of Insubria, Varese-Como, Italy (A. Spanevello); Hospital de Cruces, Vizcaya, Spain (E. Tabernero); Unit of Infectious Diseases Alma Mater Studiorum University of Bologna, Bologna, Italy (M. Tadolini); Saint John of God Catholic Hospital, Mabesseneh Lunsar, Sierra Leone (A.B.Y. Thornton); University of Sassari, Sassari, Italy (G. Sotgiu); National University of Singapore, Singapore (C.W.M. Ong)
Address for correspondence
Catherine Ong, National University of Singapore, Division of Infectious Diseases, Department of Medicine, Yong Loo Lin School of Medicine, 1E Kent Ridge Rd, 10th Fl Tower Block, Singapore 119228; email: catherine_wm_ong@nuhs.edu.sg
1These first authors contributed equally to this article.
2These senior authors contributed equally to this article.
About the Author
Prof. Migliori is director of the World Health Organization Collaborating Centre for Tuberculosis and Lung diseases at Istituti Clinici Scientifici Maugeri, Tradate, Italy, and chair of the Global Tuberculosis Network. Primary research interests are prevention, diagnosis, treatment, and rehabilitation of TB, including its relationship with COVID-19.